Keynote Speaker

Libby Dr. Peter LIBBY (5,1 Mo)
Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital, Boston, USA
Keynote Lecture "Pathophysiology of atherothrombosis"

Speakers

Fayad

Dr. Zahi FAYAD (7 Mo)
Director, Sinai Translational and Molecular Imaging Institute, NewYork, USA
Atherosclerosis

Gerszten

Dr. Robert GERSZTEN (1,5 Mo)
Director of Translational Research in the Cardiology Division at the Massachusetts General Hospital. Associate Professor of Medicine at Harvard Medical School and a Senior Associate at the Broad Institute of Harvard and MIT, Boston, USA
Metabolomics

Jaffer

Dr. Farouc JAFFER (1,2 Mo)
Director of Vascular Imaging in the Cardiovascular Molecular Imaging Program at Massachusetts General Hospital, Harvard Medical School. Attending Interventional Cardiologist at Massachusetts General Hospital, Boston, USA
Molecular Imaging

Lancelot Dr. Eric LANCELOT (1,8 Mo)
Manager of the Biology Research Department of GUERBET, a French company specialized in the research, development and production of contrast media for medical imaging. Roissy, France
Development of contrast agents for molecular magnetic resonance imaging of vulnerable atherosclerotic plaques
Lee Dr. Richard LEE (1,3 Mo)
Associate Professor of Medicine at Harvard Medical School and in Health Sciences and Technology at MIT and lecturer in Biological Engineering at MIT, Boston, USA
Markers of Mechanical Stress
Ridker Dr. Paul RIDKER (3,8 Mo)
Professor of Medicine, Harvard Medical School. Director, Center for Cardiovascular Disease Prevention
Divisions of Cardiovascular Diseases and Preventive Medicine, Brigham and Women’s Hospital, Boston, USA
Atherothrombosis
Rioufol Dr. Gilles RIOUFOL (3,4 Mo)
Associate Professor in cardiology, specializing in interventional cardiology, and researcher in the Inserm unit EMI-U 0226, Lyon, France
Can IVUS help to detect the evolution of vulnerable plaque
Sabatine Dr. Marc SABATINE (1,6 Mo)
Investigator in the Thrombolysis in Myocardial Infarction (TIMI) Study Group, and Assistant Professor of Medicine at Harvard Medical School and the Cardiovascular Medicine Division at Brigham and Women’s Hospital, Boston, USA
Acute Coronary Syndromes
Tedgui

Dr. Alain TEDGUI (4,2 Mo)
Scientific Coordinator of the first European Network of Excellence in the field of vascular biology and medicine, the European Vascular Genomics Network (EVGN), Inserm, APHP, France
Stable Atherosclerosis. Microparticules, and other Lipid-related markers.
Molecular imaging with oligonucleotides

Tiret Dr. Laurence TIRET (0,57 Mo)
Director of Research at the French Institute for Medical Research, Inserm, Paris, France
Genetics of cardiovascular diseases - From single mutations to the whole genome